OrsoBio
Operator of a clinical-stage biopharmaceutical company intended to develop therapies for organ dysfunction. The company develops therapies to treat obesity and obesity-associated disorders, including ...
Valuation
$310M
Market implied
Share Price
N/A
Total Raised
$166.6M
Last Round
N/A